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Review Article

Utility of endoscopic ultrasound in Hepato-PancreaticoBiliary (HPB) diseases
Suresh Vasan Venkatachalapathy, Andrew Baxter, Guruprasad P Aithal*
Email: guru.aithal@nottingham.ac.uk

Abstract
Endoscopic Ultrasound (EUS) has been used to diagnose benign and malignant Hepato-Pancreato-Biliary (HPB)
conditions for over 20 years. EUS allows close access to pancreas, gall bladder, left lobe of the liver and bile duct.
In particular, it is possible to sample these and other retroperitoneal tissue safely. With the introduction of novel
fork-tip and Franssen type cutting needles, the diagnostic yield has improved significantly to greater than 95%.
Hence, it has become the investigation of choice for pancreatic pathology. Contrast Enhanced EUS (CE-EUS)
may help differentiating malignant tumours from slow growing tumours such as neuroendocrine tumours and
inflammatory lesions. In addition, linear EUS has been used in a wide range of therapeutic procedures such as
drainage of pancreatic fluid collections, gall bladder empyema, biliary drainage, treatment of pancreato-biliary
tumours and coeliac plexus block/neurolysis for pain control. In this review, we will review the diagnostic and
therapeutic use of EUS in HPB conditions.
Key words: Endoscopic ultrasound, therapeutic EUS, tissue acquisition with EUS

Introduction
Intraluminal ultrasound was first used in 1956 for
the diagnosis of rectal cancer and in 1976, with
an ultrasound probe down the accessory channel
of a therapeutic gastroscope, for investigation of
a pancreatic lesion.1,2 Development in endoscopic
ultrasound (EUS) was rapid and was initially used
as a diagnostic modality for identifying benign and
malignant gastrointestinal (GI) condition. The
invention of linear echoendoscope facilitated the
endo-sonographer to acquire tissue from the lesions.
The EUS probes have either radial arrays (radial) or
curvy linear arrays (linear). Radial echoendoscopes
lack an accessory channel and their use is limited
to imaging, whereas the linear endoscopes have a
channel positioned, so that instruments advance in
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the same plane as the ultrasound image, allowing
visualization of the area of interest and the
instrument simultaneously and therefore opening
up therapeutic interventions. There is no significant
difference in imaging accuracy between either
array.3 Radial arrays are more commonly used in
staging of luminal lesions and linear arrays are
more commonly used to acquire tissue for histology
and for therapeutic interventions.
Contrast enhanced EUS (CE-EUS) was first reported
in 1997.4 Intra-arterial CO2 microbubbles and later
with the advent of power doppler sonography and
increasingly high frequency probes, venous infusion
with novel contrast agents (Sonoview) has been used
as adjuncts in the diagnosis of cystic and malignant
lesions in pancreas. 5
EUS has become an important tool and often
aid in the therapeutic management of various
Hepatico-Pancreato-Biliary conditions (HPB). The
recent advances in the accessories have facilitated
improvements in the therapeutic role of EUS. The
advantages of EUS over other modalities are it
provides safe GI access as opposed to percutaneous
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CT or ultrasound guided access (lower adverse event
rate).6 It provides close access to retroperitoneal
structures such as pancreas, left adrenal, coeliac
plexus, left lobe of the liver, gall bladder and lower
biliary tract which enables the endo-sonographer to
provide minimally invasive treatment which would
have otherwise be treated with either surgery or
interventional radiology.
EUS has a wide range of applications and in this
article; we will limit our review to the diagnostic and
therapeutic use of EUS in HPB conditions.
Choledocholithiasis
The prevalence of choledocholithiasis is 5-25%
in patients undergoing Cholecystectomy for gall
stone disease.7 Ten percent of those patients who
have gallstones may have stones in the bile duct.8
Transabdominal ultrasound (USG) and computed
tomography (CT) are less sensitive in diagnosing
choledocholithiasis compared to EUS. The
sensitivity of EUS in picking up choledocholithiasis
is 96% as compared to 71 and 63% for CT and
USG respectively.9 EUS is marginally superior
to magnetic resonance cholangio-pancreatogram
(MRCP) for diagnosing small CBD stones and
microlithiasis (accuracy 93.3% vs. 89%, NPV 97%
vs. 87.8%).10 Many centres have combined EUS and
endoscopic retrograde cholangio-pancreatography
(ERCP) procedures for suspected CBD stone disease.
Patients will have EUS first and if there are CBD
stones, will proceed to ERCP. A retrospective study
on 206 patients demonstrated that such an approach
is safe in elderly population.11 The procedure can be
done with conscious sedation. The procedure related
complications and sedation related complications
were not different to either ERCP or EUS done
alone.12
Staging of pancreatic cancer and tissue
acquisition
EUS can be used to assess the vascular invasion of
the coeliac artery, superior mesenteric artery (SMA)
and portal vein (PV) in patients with pancreatic
cancer. In a recent study, the diagnostic accuracy of
EUS in assessing SMA involvement was 87% and the
PV involvement was 92%.13 However, considering
well described limitations of individual imaging

modalities in the staging of pancreatic cancer, EUS
is used to assist decision making in selected patients
where staging from cross sectional imaging is
equivocal and risks of an exploratory laparotomy
with an intention to resect are deemed substantial.
Contrast enhanced EUS (CE-EUS) may help
differentiating malignant tumours from slow
growing tumours such as neuroendocrine tumours
and inflammatory lesions. Normal tissue has a
homogenous enhancement during the arterial
phase. Ductal adenocarcinomas are hypo-enhancing,
inflammatory lesions are iso or hyper-enhancing
and neuroendocrine tumours show hyperenhancement. A retrospective study involving 210
patients reported that the sensitivity, specificity and
diagnostic accuracy of CE-EUS in differentiating
pancreatic cancer from neuroendocrine tumours and
mass forming pancreatitis was 83%, 87% and 84%
respectively.14 EUS elastography can be an added
adjunct for differentiating malignant lesions from
benign pancreatic lesions. Malignant lesions are likely
to have higher stiffness compared to benign lesions. It
is easier to demonstrate with new generation stacks.
A retrospective study of 218 patients reported that
the sensitivity, specificity, PPV and NPV for high
stiffness in identifying malignancy was 84%, 67%,
56% and 89% respectively.15 A prospective study on
62 patients reported that combining the CE-EUS
and elastography improved the diagnostic accuracy
to 92% in diagnosing pancreatic malignancies.16
The advantage of EUS over other imaging modalities
is the opportunity for sampling to confirm the
diagnosis. A recent meta-analysis on 828 patients on
EUS guided fine needle biopsy (FNB) of pancreatic
lesions reported a sensitivity of 85% and a specificity
of 98%.17 However, the new generation fork tip
cutting needles may have a higher diagnostic yield
compared to the conventional needles. A prospective
study comparing the new needle and historic
fine needle aspiration (FNA) samples reported a
diagnostic yield of 96% vs. 88%.18Another casecontrol study reported similar histological yield
for the fork tip needle (Figure 1) but with reduced
number of passes compared to the FNA needle (95%
vs. 59%, P=0.01).19 A retrospective study on FNB
needle showed that the sample was adequate in 90%
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of the patients. The sensitivity and specificity for
diagnosis was 93% and 100% respectively.20

Figure 1: Fork tip needle

Chronic pancreatitis (CP)
EUS allows close assessment of the structure
and architecture of the pancreas providing
information of pancreatic parenchyma, pancreatic
duct (PD), calcification, cysts and strictures. It is
more sensitive and has comparable specificity in
diagnosing chronic pancreatitis than CT or MRI.21
Parenchymal features of chronic pancreatitis
notable on EUS include hyperechoic foci, stranding,
lobularity, honeycombing (contiguous lobularity)
and cyst formation. The ductal features of chronic
pancreatitis are PD stones, dilatation of PD and
side branches, irregular main PD contour and
hyperechoic duct margins. Rosemount criteria are
widely used to diagnose CP using EUS.22 As these
are based on a subjective assessment, there is an
inter-observer variability which may be one of the
limiting factors of EUS as a test in this scenario. A
prospective study comparing EUS features against
endoscopic pancreatic function test reported that the
specificity and negative predictive value of CP was
100% if they have more than five EUS features of
CP on EUS.23
EUS elastography may have a role as an adjunct to
conventional EUS. Elastography assesses the strain
in the tissue arising from compression. It can also
be quantitatively assessed by calculating the strain
ratio between the region of interest and reference
area. A prospective study on 191 patients with CP
showed a significant linear correlation between
number of criteria and strain ratio (r = 0.813;
P < 0.0001). The overall diagnostic accuracy for
EUS-elastography in diagnosing CP was 91.1%.24
3
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A prospective observational study on 115 patients
with CP reported that there was a direct relationship
between strain ratio and pancreatic exocrine
insufficiency (PEI). The probability of PEI rose
from 4.2% if their strain ratio was less than 2.5 to
93% and if their SR was greater than 5.5%.25
Drainage of pancreatic fluid collections
Pancreatic fluid collections (PFC) develop secondary
to pancreatic duct injury and are classified in
to acute peri-pancreatic fluid collections, acute
necrotic collection, walled off necrosis (WON)
and pseudocysts (PP).26 Acute peri-pancreatic and
acute necrotic collections develops within four
weeks of the attack of pancreatitis and do not have
well defined walls around the collection. They may
not need any intervention unless they are infected
and may resolve on its own. Walled off necrosis
and pseudocysts develop after four weeks of the
acute insult and are more organized and may take
several weeks to months to resolve spontaneously.
In symptomatic patients, these need to be drained.
In the past, symptomatic walled off necrosis and
pseudocysts were drained either through surgical
cyst gastrostomy or percutaneous drainage under
CT or ultrasound guidance. EUS guided drainage
of PFC was first reported in 1992.27 The advantages
of EUS were it allowed the endo-sonographers have
close access to the collection, visualize the collection,
avoid blood vessels and deploy stent under x-ray
guidance. Since then, there have been many studies
reporting EUS guided drainage with success rates
of 80-100% and complication rates of 10-20%. 28-30
A randomised controlled trial in 2013 comparing
surgical cyst gastrostomy with EUS-cyst
gastrostomy reported a reduced morbidity and
length of stay associated with the EUS based
approach.31 The TENSION trial which compared
surgical with endoscopic step up approach, reported
reduced length of stay, reduced rate of pancreatic
fistula formation and a significant reduction in costs
with endoscopic step up approach even though
superiority of the endoscopic step up group was not
shown.32 Hence, EUS guided drainage is increasingly
used as first line treatment in the management of
PFC.
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The different types of stents used in the drainage
of PFC include plastic double pigtail stents, fully
covered self-expanding metal stents (FC-SEMS) and
lumen apposing metal stents (LAMS). Plastic stents
are as efficacious as metal stents (Figure 2) in the
drainage of uncomplicated pseudocysts. However,
they are less efficacious and have a high serious
adverse event if the collection is infected or if it is
a walled off necrosis.33A retrospective comparative
study reported that double pigtail stents were the
sole negative predictive factor in the drainage of
walled off necrosis, on multivariate analysis.33

drainage of WON reported that the mean number
of endoscopic procedures (direct endoscopic
necrosectomy) required for the resolution of the
collections was significantly lower in the LAMS
group compared to the FC-SEMS or plastic stent
groups (2.2 vs. 3 vs. 3.6, respectively; P =0.04).33

Although FC-SEMS are effective allowing for
effective debridement, risk of stent migration
between 10-20% remains an issue. Three
retrospective studies reported a success rate of 8094% for the drainage of PFC with a serious adverse
event rate of 20%.30,34,35

Gall bladder drainage
The treatment of choice for acute cholecystitis
is cholecystectomy, but in a small proportion of
patients this may not be possible because of old
age and comorbidities. The alternative treatment
is radiologically guided percutaneous drainage of
the gall bladder especially if they have gall bladder
empyema. EUS guided gall bladder drainage was first
reported in 2007 has advantages over percutaneous
intervention. It does not require external drain
and offer Transmural drainage in to the GI tract
which is associated with reduced length of stay,
fewer interventions and adverse events compared
to percutaneous cholecystostomy or trans-papillary
endoscopic cystic duct drainage.41-43A multi-centre
prospective study assessing the long term efficacy
of LAMS reported a technical success rate of 90%
and clinical success rate of 96%.44

Figure 2: LAMS

LAMS partially deployed

High rates of stent migration have led to increasing
use of LAMS which were designed to reduce stent
migration. Multiple studies have reported a technical
success rate of 97-99%, clinical success rates of
91-94% reducing serious adverse event rates to
8-11% and stent migration rates to 5-7%. A recent
retrospective study of 313 patients comparing
plastic stents to two forms of metal stents in the

Irrespective of the stent used, EUS guided drainage
of PFC is minimally invasive, associated with reduced
mortality, reduced morbidity, reduced length of stay
in hospital and reduced SAE compared to surgical or
radiological intervention.

Biliary drainage
ERCP is the conventional mode of achieving biliary
drainage when patients present with obstructive
jaundice secondary to malignant biliary obstruction.

Table 1: Technical and clinical success rate of fully covered metal stent (FCSEMS) and lumen apposing metal stent (LAMS)
Author

Study
design

Single
centre/

Sample
Size

LAMS

R

M

116

LAMS

R

M

82

2016

LAMS

R

M

124

Year

Stent type

Venkatachalapathy36

2018

Siddiqui37

2016

Sharaiha

38

Rinninella

Technical
success %

Clinical
success %

SAE %

Stent

99

94

11.2

6.4

98.7

N/A

9.8

2.4

100

86.3

18.5

5.6

2015

LAMS

R

M

93

98.7

92.5

5.3

N/A

Shah40

2015

LAMS

R

M

33

91

91

6.4

3.22

Vazquez-sequeiros35

2016

FCSEMS

R

M

211

97

85

25

5

Huggett30

2015

FCSEMS

R

M

19

100

N/A

26

20

M

47

98.1

76.6

24.2

18.5

39

2014 FCSEMS
R
Chandran34
R=Retrospective, P=Prospective, M= Multi-centre, S= Single centre
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ERCP-guided biliary drainage is successful in 8090% of cases, but selective bile duct cannulation may
not be possible because of altered anatomy, duodenal
obstruction, duodenal diverticulum, distorted
ampulla, failed cannulation and in situ duodenal
stents. Hence, in up to one in five patients biliary
drainage may not be possible with ERCP.
Percutaneous transhepatic cholangiography (PTC)
approach has a success rate of 88-98% in achieving
biliary drainage; in those patients who had a failed
ERCP. The major complication rate varies from
8-35% and a recent study from United Kingdom,
using hospital episode statistics (HES) on 16,363
patients, reported inpatient mortality of 15%, 30day mortality of 23.1% and a major complication
rate of 35%.

proximity of the scope to the coeliac axis. This
helps to place the needle (Figure 3) accurately and
enhances the spread of injection. Three metaanalysis involving 803 patients reported that in
patients with inoperable pancreatic cancer EUSguided CPN alleviates pain in 70%–80% of patients
at 8 weeks. The pain relief was higher in patients
who received injections on both sides of coeliac
artery.49-51
In patients with chronic pancreatitis, the pain relief
was 50%–60% at 8 weeks. The main drawback of this
treatment is that the pain relief is not permanent
and it recurs after 8–12 weeks.

EUS-BD
(EUS
biliary
drainage
or
choledochoduodenostomy) was first described in
200145and since then several studies have reported
outcomes on EUS-guided biliary drainage in
patients who had a failed ERCP. There are three
modes one can establish biliary drainage. They are
1. Transduodenal route for distal CBD strictures
(choledocho-duodenostomy), 2. Trans-gastric route
for hilar strictures (hepatico-gastrostomy) and 3.
EUS guided rendezvous especially for patients who
have diverticulum or in those where the ampulla is not
visible. Two systematic reviews and meta-analysis
comparing EUS-BD and percutaneous approach;
involving 9 studies (483 patients) and 6 studies (312
patients) reported that there was no difference in
technical success between the two procedures but
EUS BD was associated with better clinical success,
lower re-intervention rate and reduced moderate
to serious adverse event rate.46,47A multicentre
randomized control trial comparing EUS-BD vs.
ERCP showed marginally higher success rate,
reduced adverse event rate(6.3% vs. 19.7%, P = 0.03)
and reduced post procedure pancreatitis rate (0 vs.
14.8%) in the EUS-BD group.48

EUS guided treatment for pancreato-biliary
tumours
EUS guided ablation of pancreatic cyst lesions
have been reported in literature. Most of the case
series used ethanol as an ablation agent. A recent
prospective randomized control trial of 39 patients
with mucinous cysts comparing alcohol vs. alcohol
free (Normal saline) reported a successful ablation
rate of 67 vs. 64% complete ablation rate at 6
months. Patients were randomly assigned to 1 of 2
groups that underwent EUS-guided pancreatic cyst
lavage with either 80% ethanol (control) or normal
saline (alcohol-free group). Cysts in both groups
were then infused with an admixture of paclitaxel
and gemcitabine. The serious adverse event rate was
significantly lower in the alcohol free group.52

EUS guided coeliac plexus block/neurolysis
The advantages of EUS guided coeliac plexus
neurolysis (CPN) over percutaneous approach are
that accurate localization of coeliac plexus, clear
definition of coeliac axis anatomy and the close

EUS guided radiofrequency ablation of solid and
cystic lesions of the pancreas are being studied
but they are not used outside the research studies.
CyberKnife stereotactic radiotherapy has been
used to treat pancreatic cancers. The radiographic

5
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Figure 3: Coeliac plexus neurolysis needle with hole on the side
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markers (Fiducial markers) are placed around the
tumour to deliver direct beam radiation precisely
over the target. As EUS allows close proximity to
the lesion, it allows successful placement of these
fiducials.53
Conclusion
In conclusion, endoscopic ultrasound can be used
to diagnose and stage Hepato-Pancreato- Biliary
diseases. As it allows the endo-sonographer to
achieve close access the retroperitoneal organs,
bile duct, liver and gall bladder, it is relatively safe
in delivering minimally invasive treatments to the
above organs.
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